TXG
10X Genomics Inc
Price:  
13.01 
USD
Volume:  
4,037,398.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TXG Relative Valuation

-381.3%
Upside

As of 2025-07-07, the Relative Valuation of 10X Genomics Inc (TXG) is (36.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.01 USD, the upside of 10X Genomics Inc based on Relative Valuation is -381.3%.

The range of the Relative Valuation is (37.78) - (36.55) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.6x - 31.3x 29.7x
Forward P/E multiples 26.2x - 28.7x 27.7x
Fair Price (37.78) - (36.55) (36.60)
Upside -390.4% - -381.0% -381.3%
13.01 USD
Stock Price
(36.60) USD
Fair Price

TXG Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 -10.20
2025-07-02 -10.20
2025-07-01 -9.46
2025-06-30 -9.08
2025-06-27 -9.20
2025-06-26 -9.17
2025-06-25 -9.14
2025-06-24 -8.54
2025-06-23 -8.46
2025-06-20 -8.48
2025-06-18 -8.52
2025-06-17 -8.28
2025-06-16 -8.63
2025-06-13 -8.17
2025-06-12 -8.30
2025-06-11 -8.45
2025-06-10 -8.35
2025-06-09 -7.91
2025-06-06 -7.39
2025-06-05 -7.14
2025-06-04 -7.32
2025-06-03 -7.14
2025-06-02 -7.41
2025-05-30 -7.47
2025-05-29 -7.32
2025-05-28 -6.95
2025-05-27 -6.74
2025-05-23 -6.41
2025-05-22 -6.70
2025-05-21 -6.52
2025-05-20 -7.12
2025-05-19 -7.00
2025-05-16 -7.36
2025-05-15 -7.21
2025-05-14 -7.15
2025-05-13 -7.57
2025-05-12 -7.44
2025-05-09 -6.88
2025-05-08 -6.77
2025-05-07 -6.52
2025-05-06 -6.35
2025-05-05 -6.75
2025-05-02 -6.61
2025-05-01 -6.35
2025-04-30 -6.48
2025-04-29 -6.57
2025-04-28 -6.65
2025-04-25 -6.51
2025-04-24 -6.52
2025-04-23 -6.28